A Study to Investigate Leramistat in Patients With IPF

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

NCT04552899 ·Status: TERMINATED ·Phase: PHASE3

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

NCT03711162 ·Status: TERMINATED ·Phase: PHASE3

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT03955146 ·Status: TERMINATED ·Phase: PHASE3

A Study of RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-Emphysema

NCT05466747 ·Status: WITHDRAWN ·Phase: PHASE4

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT03591926 ·Status: WITHDRAWN ·Phase: PHASE2

Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

NCT06331624 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT01254409 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)

NCT01769196 ·Status: TERMINATED ·Phase: PHASE2

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

NCT05130970 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT02550873 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT03832946 ·Status: COMPLETED ·Phase: PHASE2

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT05571059 ·Status: RECRUITING ·Phase: PHASE2

Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

NCT04598919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

NCT04419506 ·Status: COMPLETED ·Phase: PHASE2

Atezolizumab for Idiopathic Pulmonary Fibrosis

NCT05515627 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

NCT04308681 ·Status: COMPLETED ·Phase: PHASE2

Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

NCT05671835 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

NCT03573505 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients

NCT05954988 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

NCT03733444 ·Status: TERMINATED ·Phase: PHASE3

A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT02477709 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT06317285 ·Status: TERMINATED ·Phase: PHASE2

A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

NCT05321069 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

NCT00650091 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

NCT05424887 ·Status: UNKNOWN ·Phase: PHASE2